- Speaker
-
David Ledbetter, Ph.D., FACMGExecutive Vice President & Chief Scientific Officer, Geisinger Health System
Presidential Lectures are a series of free public colloquia spotlighting groundbreaking research across four themes: neuroscience and autism science, physics, biology, and mathematics and computer science. These curated, high-level scientific talks feature leading scientists and mathematicians and are designed to foster discussion and drive discovery within the New York City research community. We invite those interested in these topics to join us for this weekly lecture series.
Healthcare providers, government agencies and research groups are using data drawn from decades of electronic medical records to improve patient care and to identify the genetic mutations responsible for conditions such as autism spectrum disorders. Called the Learning Health System model, the approach is helping transform the health care system into one that can more rapidly learn, adapt and improve.
In this lecture, Dr. David Ledbetter will describe Geisinger Health System’s Precision Health Center. The center makes available more than 20 years’ worth of electronic health data for research and innovation. In partnership with Regeneron Genetics Center, Geisinger now has exome sequence data for more than 92,000 patient-participants, with an ultimate goal of 250,000. Those data have already led to the successful identification of new drug targets, improved prevalence estimates of the most common Mendelian disorders (FH, BRCA, Lynch) and the identification of autism spectrum and neuropsychiatric CNV disorders in 0.8 percent of the dataset’s adult participants. These results are already having a positive impact on individual participants, their family members and their primary care physicians.
About the Speaker
Dr.Ledbetter is a human geneticist with ABMGG board-certification in clinical cytogenetics. Since his discovery of the genetic causes of Prader-Willi syndrome and Miller-Dieker syndrome, his research has focused on developing and applying technologies to better understand neurodevelopmental conditions such as autism spectrum disorders. He has held leadership positions at NIH, the University of Chicago, and Emory University and is currently the executive vice president and chief scientific officer of Geisinger Health System.